within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P02C_AntinematodalAgents.P02CB01_Piperazine;
model Piperazine 
   extends Pharmacolibrary.Drugs.ATC.P.P02CB01;

  annotation(Documentation(
    info ="<html><body><p>Piperazine is an anthelmintic drug historically used for the treatment of intestinal nematode infections, primarily ascariasis and enterobiasis (pinworm). It paralyzes helminths by acting as a GABA agonist at the neuromuscular junction, making them more easily removed from the host's intestines. Its use has decreased with the introduction of more effective drugs, but it is still available in some regions for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects following oral administration.</p><h4>References</h4><ol><li><p>Kim, EY, et al., &amp; Lee, K (2015). Effect of Piperazine Dithioctate on the Oral Pharmacokinetics of Glimepiride in Rats. <i>Biological &amp; pharmaceutical bulletin</i> 38(8) 1161–1168. DOI:<a href=&quot;https://doi.org/10.1248/bpb.b15-00044&quot;>10.1248/bpb.b15-00044</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26235578/&quot;>https://pubmed.ncbi.nlm.nih.gov/26235578</a></p></li><li><p>Peng, B, et al., &amp; Schran, H (2005). Clinical pharmacokinetics of imatinib. <i>Clinical pharmacokinetics</i> 44(9) 879–894. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544090-00001&quot;>10.2165/00003088-200544090-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16122278/&quot;>https://pubmed.ncbi.nlm.nih.gov/16122278</a></p></li><li><p>Halas, CJ (2006). Eszopiclone. <i>American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists</i> 63(1) 41–48. DOI:<a href=&quot;https://doi.org/10.2146/ajhp050357&quot;>10.2146/ajhp050357</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16373464/&quot;>https://pubmed.ncbi.nlm.nih.gov/16373464</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Piperazine;
